1. Inicio
  2. Proyectos y Estudios
  3. ESTUDIO OBSERVACIONAL RETROSPECTIVO PARA DESCRIBIR LA RESPUESTA AL LEAD-IN CON PEGINTERFERON/RIBAVIRINA COMO HERRAMIENTA DE DECISIÓN CLÍNICA EN PACIENTES TRATADOS CON VICTRELIS (BOCEPREVIR).

ESTUDIO OBSERVACIONAL RETROSPECTIVO PARA DESCRIBIR LA RESPUESTA AL LEAD-IN CON PEGINTERFERON/RIBAVIRINA COMO HERRAMIENTA DE DECISIÓN CLÍNICA EN PACIENTES TRATADOS CON VICTRELIS (BOCEPREVIR).

Datos básicos

Código:
MSD-BOC-2012-01
Protocolo:
MSD-BOC-2012-01
EUDRACT:
NCT:
Centro:
Dotación:
Año de incio:
Año de finalización:
ESTUDIO OBSERVACIONAL

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

MERCK SHARP & DOHME DE ESPAÑA S.A.

Resultados del Ensayo Clínico

HOW SHOULD I MANAGE HBV IN THE WAITLISTED PATIENT?

MARINA BERENGUER HAYM, J. FUNG

Capítulo de un Libro. 2017


"Posttransplant calcineurin inhibitors levels and intra-patient variability are not associated with long term outcomes following liver transplantation".

Di Maira T; (...); Berenguer M

Article. 10.1097/TP.0000000000002987. 2020


[Hepatitis C treatment in special patient groups].

Berenguer, Marina; (...); Castellano, Gregorio

Article. 2014


A Century of Progress on Wilson Disease and the Enduring Challenges of Genetics, Diagnosis, and Treatment.

Penning, Louis C.; (...); Weiskirchen, Ralf

Article. 10.3390/biomedicines11020420. 2023


A multicenter study to assess the incidence of hepatocellular carcinoma recurrence after liver transplantation in patients treated with direct-acting antivirals for chronic hepatitis C

Gorgen, A; (...); Sapisochin, G

Meeting Abstract. 2018


A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area.

Carvalho-Gomes Â; (...); Berenguer M

Article. 10.1371/journal.pone.0228351. 2020


Access to liver transplant for women in Spain: a national registry analysis

Tejedor Bravo, Marta; (...); Berenguer, Marina

Meeting Abstract. 2023


Access to liver transplant for women in Spain: a national registry analysis

Tejedor, M.; (...); Berenguer, M.

Meeting Abstract. 2023


Acute cellular rejection versus recurrent hepatitis C after liver transplantation: Clinical and pathological features driving a rational diagnostic approach

de la Peña-Moral JM; (...); Parrilla P

Article. 10.1111/hepr.12369. 2015


Adaptation and validation of an abbreviated version of the SIPAT integrated psychosocial risk scale in patients with liver cirrhosis candidates for liver transplantation (SIPAT-11).

Garcia Morales, Natalia; (...); Cubiella, Joaquin

Article. 10.1016/j.gastrohep.2024.502220. 2024


Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience.

Andacoglu, Oya; (...); Selzner, Nazia

Article. 10.3389/ti.2023.11240. 2023


ADVERSE EFFECTS OF TRIPLE THERAPY WITH BOCEPREVIR (BOC) AND TELAPREVIR (TVR) IN CLINICAL PRACTICE IN PATIENTS WITH ADVANCED HEPATIC FIBROSIS

Salmeron, J.; (...); Prieto, M.

Article. 10.1016/S0168-8278(14)61356-8. 2014


Albumin dialysis with MARS for the treatment of anabolic steroid-induced cholestasis

Diaz, FC; (...); Prieto, M

Article. 10.5604/16652681.1222114. 2016


Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives.

Gitto S; (...); Berenguer M

Editorial Material. 10.1155/2019/8691502. 2019


Alterations in carbohydrate metabolism in cirrhotic patients before and after liver transplant

Ramos-Prol A; (...); Merino-Torres JF

Article. 10.1016/j.diabres.2015.10.002. 2015


Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting The MENTE Study

Rodríguez-Nóvoa S; (...); Castro Á

Article. 10.1097/MCG.0000000000000569. 2016


Altered underlying tubular function in HBV monoinfected patients receiving nucleos(t)ide analogs in a real-world setting: MENTE Study

Rodriguez Novoa, Sonia; (...); Castro, Angeles

Article. 2014


An objective definition for clinical suspicion of T-cell-mediated rejection after liver transplantation

Rodriguez-Peralvarez, M; (...); De la Mata, M

Article. 10.1111/ctr.13005. 2017


ANABOLIC ANDROGENIC STEROIDS (AAS) ILLICIT USE IS A RAPIDLY GROWING CAUSE OF DRUG-INDUCED LIVER INJURY (DILI): A PROSPECTIVE SERIES FROM THE SPANISH-LATIN-AMERICAN DILI REGISTRY

Medina-Caliz, I.; (...); Andrade, R. J.

Article. 10.1016/S0168-8278(14)60472-4. 2014


Anesthesia and Critical Care for the Prediction and Prevention for Small-for-size Syndrome: Guidelines from the ILTS-iLDLT-LTSI Consensus Conference.

Chadha, Ryan; (...); Rela, Mohamed

Article. 10.1097/TP.0000000000004803. 2023


Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List?

Tejedor, Marta, Selzner, Nazia, Berenguer, Marina

Article. 10.1097/TP.0000000000004163. 2022


Assessment of persistent COVID-19 in liver transplant recipients compared to immunocompetent individuals

Fernandez, A.; (...); Salcedo, M. M.

Meeting Abstract. 2023


Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation Study

Puchades, L; (...); Lai, JC

Article. 10.1097/TP.0000000000002025. 2018


ATP7B AND OTHER GENES RESULTING IN WILSON DISEASE (WD) PHENOTYPE

Sanchez-Monteagudo, A; (...); Berenguer, M

Meeting Abstract. 2019


Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen alleles

Stephens, C; (...); Lucena, MI

Article. 10.1097/FPC.0000000000000230. 2016


Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.

Martí-Aguado D; (...); Martí-Bonmatí L

Article. 10.1148/radiol.2021211027. 2022


Avances en el tratamiento de la hepatitis C.

Vinaixa C, Aguilera V, Berenguer M

Abstract of Published Item. 10.1016/j.medcli.2013.01.041. 2013


Baseline features of hepatitis C patients associated to prescription of pangenotypic antiviral treatments: results from the real-world Spanish Hepa-C registry

Turnes, Juan; (...); Perez Cachafeiro, Santiago

Meeting Abstract. 2020


Beyond cure: preventing and managing the complications of end-stage liver disease

Berenguer M; (...); Puoti M

Review. 10.1097/COH.0000000000000184. 2015


Brain abscesses in early post-liver transplantation.

Mínguez Sabater A; (...); Prieto Castillo M

Case Reports. 10.1016/j.eimc.2021.02.002. 2021


Brain abscesses in early post-liver transplantation.

Minguez Sabater, Alejandro; (...); Prieto Castillo, Martin

Article. 10.1016/j.eimce.2021.09.007. 2021


CA125: a new biomarker in patients with Fontan circulation (vol 76, pg 112, 2023)

Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda

Correction. 10.1016/j.rec.2023.03.018. 2023


CA125: a new biomarker in patients with Fontan circulation.

Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda

Article. 10.1016/j.rec.2022.05.029. 2022


Can endothelial biomarkers before liver transplantation together with classical cardiovasculat risk factors be useful to predict cardiovascular risk after liver transplantation

Herreras Lopez, Julia; (...); Aguilera Sancho, Victoria

Meeting Abstract. 2022


Can endothelial biomarkers before LT together with classical cardiovascular risk factors be useful to predict cardiovascular risk after LT?

Herreras, J.; (...); Aguilera, V.

Article. 2022


Circulating MicroRNAs: Dynamic Markers of Liver Transplant Injury.

Mas VR, Bardhi E, Berenguer M

Article. 10.1097/TP.0000000000003816. 2021


Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease.

Simao, Andre Lopes; (...); Castro, Rui E

Article. 10.1016/j.jhepr.2023.100697. 2023


Clinical and molecular characterization of Wilson's disease in the Valencian Region

Sanchez-Monteagudo, A; (...); Espinos, C

Meeting Abstract. 2018


Clinical characteristics and outcomes of elderly included in the Spanish Drug-Induced Liver Injury (DILI) Registry

Slim, M; (...); Andrade, RJ

Meeting Abstract. 10.1016/S0168-8278(17)31154-6. 2017


Clinical features and risk factors associated with Non-alcoholic steatohepatitis (NASH) in Spain. On behalf of HEPAmet Registry

Gallego-Duran, Rocio; (...); Romero-Gomez, Manuel

Article. 2015


Clinical Outcomes in biopsy-proven NAFLD patients from the HEPAmet Spanish Registry

Ampuero, J; (...); Gomez, MR

Meeting Abstract. 10.1016/S0168-8278(18)31942-1. 2018


Clinical outcomes of patients delisted from thewaiting list of liver transplantation after interferon-free antiviral therapy

Pascasio, JM; (...); Londono, MC

Meeting Abstract. 10.1016/S0168-8278(17)30661-X. 2017


Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation

Pascasio, JM; (...); Londoño MC

Article. 10.1016/j.jhep.2017.08.008. 2017


CLINICAL PRESENTATION AND OUTCOMES OF DE NOVO HEPATITIS B VIRUS INFECTION AFTER LIVER TRANSPLANTATION IN SPAIN.

Pascasio Acevedo, Juan Manuel; (...); Manuel Sousa, Jose

Meeting Abstract. 2019


CMV reactivation (rCMV) is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplatatoin (LT)

Aguilera, V.; (...); Berenguer, M.

Meeting Abstract. 2023


CMV reactivation after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study

Garcia-Garcia, Sonia; (...); Aguilera Sancho, Victoria

Meeting Abstract. 2023


CMV reactivation is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT)

Aguilera Sancho, Victoria; (...); Berenguer, Marina

Meeting Abstract. 2022


COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.

Kowdley KV; (...); Villamil A

Article. 10.14309/ajg.0000000000003029. 2024


Combined Resistance and Endurance Training at a Moderate-to-High Intensity Improves Physical Condition and Quality of Life in Liver Transplant Patients

Moya-Najera, D; (...); Colado, JC

Article. 10.1002/lt.24827. 2017


Comparative effects of second-line therapy with obeticholic acid or fibrates in primary biliary cholangitis patients

Reig, Anna; (...); Pares, Albert

Meeting Abstract. 2020


Comparison of results of combined liver-kidney transplantation vs. isolated liver transplantation.

Aguilera V; (...); Mir J

Article. 10.1016/S1665-2681(19)31366-3. 2013


Comprehensive analysis and insights gained from long-term experience of the Spanish DILI registry.

Stephens C; (...); Andrade RJ

Article. 10.1016/j.jhep.2021.01.029. 2021


Computational models of liver fibrosis progression for hepatitis C virus chronic infection

Lara J; (...); Khudyakov YE

Article. 10.1186/1471-2105-15-S8-S5. 2014


Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020).

Rodríguez M; (...); García-Samaniego J

Article. 10.1016/j.gastrohep.2020.03.011. 2020


Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline

Aller, R; (...); Romero-Gomez, M

Correction. 10.1016/j.gastrohep.2018.05.011. 2018


Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline

Aller, R; (...); Romero-Gomez, M

Review. 10.1016/j.gastrohep.2017.12.003. 2018


Control of Diabetes Mellitus in Liver Transplant Recipients

Ramos-Prol, Agustin; (...); Francisco Merino-Torres, Juan

Article. 2014


Controlling Diabetes After Liver Transplantation: Room for Improvement

Alvarez-Sotomayor D; (...); Berenguer M

Article. 10.1097/TP.0000000000001399. 2016


Correction to COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.

Kowdley, Kris V; (...); Villamil, Alejandra

Article. 10.14309/ajg.0000000000003153. 2024


Corrigendum to "Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives".

Gitt S; (...); Berenguer M

Correction. 10.1155/2020/4305190. 2020

  • Open Access.

COVID vaccination among liver transplant recipients: A EASL-ESOT/ELITA-ILTS multi society survey

Vinaixa, Carmen; (...); Berenguer, Marina

Meeting Abstract. 2022


COVID vaccination among liver transplant recipients: an EASL-ESOT/ELITA-ILTS multi-society international survey

Vinaixa, C.; (...); Berenguer, M.

Meeting Abstract. 2022


COVID-19 and liver transplantation

Di Maira T, Berenguer M

Editorial Material. 10.1038/s41575-020-0347-z. 2020


Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation

Rodriguez-Peralvarez, Manuel; (...); Gomez Bravo, Miguel Angel

Meeting Abstract. 2022

  • Open Access.

Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective study

Aguilera, V; (...); Berenguer, M

Article. 10.1111/tri.13145. 2018


Cytomegalovirus reactivation is associated with lower hepatocelullar carcinoma recurrence rates after liver transplantation

Aguilera Sancho, Victoria; (...); Rodriguez-Peralvarez, Manuel

Meeting Abstract. 2023


CYTOMEGALOVIRUS SPECIFIC POLYFUNCTIONAL T-CELL RESPONSES EXPRESSING CD107A ASSOCIATED WITH CONTROL OF CMV REACTIVATION AFTER LIVER TRANSPLANTATION

Carvalho-Gomes, A; (...); Aguilera, V

Meeting Abstract. 2021


Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantation.

Carvalho-Gomes Â; (...); López-Labrador FX

Article. 10.1016/j.cellimm.2021.104455. 2022


Cytomegalovirus specific polyfunctional T-cells control CMV reactivation after liver transplantation

Carvalho-Gomes, A; (...); Aguilera, V

Meeting Abstract. 2021


Cytomegalovirus specific polyfunctional t-cells control CMV reactivation, after liver transplantation

Carvalho-Gomes, Angela; (...); Sancho, Victoria Aguilera

Meeting Abstract. 2024


Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients

Marcos, AC; (...); Pons, JA

Meeting Abstract. 2021

  • Open Access.

Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients

Caballero-Marcos, A; (...); Pons, JA

Article. 10.1111/ajt.16599. 2021


Changing delta hepatitis patient profile: A single center experience in Valencia region, Spain

Hernandez-Evole, H, Briz-Redon, A, Berenguer, M

Article. 10.4254/wjh.v12.i6.277. 2020


Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: Experience of a transplant center in the Mediterranean basin.

Mínguez Sabater A; (...); Berenguer, Marina

Article. 10.1016/j.gastrohep.2021.03.017. 2022


CHARACTERISTICS AND IMPACT OF SEX IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER STUDY FROM A CLASSICALLY LOW PREVALENCE AREA

Minguez, Alejandro; (...); Berenguer, Marina

Meeting Abstract. 2021


Characteristics and trends of liver transplantation in a cohort of patients with primary sclerosing cholangitis: a retrospective multicenter study

Minguez, A.; (...); Berenguer, M.

Meeting Abstract. 2022


Characteristics, trends and outcomes of liver transplantation (LT) for primary sclerosing cholangitis (PSC) in female patients: analysis of the European Liver Transplantation Registry (ELTR)

Di Maira, T; (...); European Liver & Intestine

Meeting Abstract. 2021


Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry

Berenguer M; (...); European Liver Intestine Transplan

Article. 10.1097/TP.0000000000003542. 2021


CHARACTERIZATION OF HBsAg LOSS IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH NUCLEOS/TIDE ANALOGS (NUCS): A RETROSPECTIVE MULTICENTER STUDY (HEBESAS)

Suarez, E.; (...); Fuentes, J.

Article. 10.1016/S0168-8278(15)30854-0. 2015


Characterizing chronic hepatitis delta in Spain and the gaps in its management

Rodriguez-Tajes, Sergio; (...); Lens, Sabela

Meeting Abstract. 2023


Characterizing Hepatitis Delta in Spain and the gaps in its management.

Rodriguez-Tajes, Sergio; (...); Lens, Sabela

Article. 10.1016/j.gastrohep.2024.502222. 2024


Chronic kidney disease after liver transplantation: pretransplantation risk factors and predictors during follow-up.

Giusto M; (...); Merli M

Article. 10.1097/TP.0b013e3182884890. 2013


Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection

Fontana RJ; (...); Reddy KR

Article. 10.1002/lt.24416. 2016


Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019.

Caballero-Marcos, Aranzazu; (...); Salcedo, Magdalena

Article. 10.1002/lt.26389. 2022


Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.

Chen Q; (...); Quer J

Article. 10.1016/j.antiviral.2019.104694. 2020


Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects

Ampuero, Javier; (...); Romero-Gomez, Manuel

Article. 10.1111/liv.14898. 2021


Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury

Medina-Caliz, I; (...); Spanish DILI Registry

Article. 10.1016/j.jhep.2016.05.003. 2016


Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting

Perricone, G; (...); European Liver Intestine Transpla

Article. 10.1111/liv.13878. 2018


Delisting of Liver Transplant Candidates with Chronic HCV Infection after Viral Erradication: Outcome 2 Years after Delisting. A European Study

Vinaixa, C; (...); Duvuox, C

Meeting Abstract. 10.1097/01.tp.0000542536.91165.49. 2018


Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study

Belli LS; (...); European Liver and Intestine Association (ELITA)

Article. 10.1016/j.jhep.2016.05.010. 2016


Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European study

Belli, LS; (...); Duvoux, C

Meeting Abstract. 10.1016/S0168-8278(17)30339-2. 2017


Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis (vol 22, pg 2062, 2024)

De Vincentis, A.; (...); Conde, Isabel

Correction. 2025


Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.

De Vincentis, Antonio; (...); Carbone, Marco

Article. 10.1016/j.cgh.2024.05.008. 2024


Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR-MASH score

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Article. 10.1111/liv.15766. 2024


Development and Validation of Hepamet Fibrosis Scoring System-a Simple, Non-invasive Test to Identify Patients With Nonalcoholic Fatty liver Disease With Advanced Fibrosis.

Ampuero J; (...); Del Pozo Maroto E

Article. 10.1016/j.cgh.2019.05.051. 2020


Digital Pathology Enables Automated and Quantitative Assessment of Inflammatory Activity in Patients with Chronic Liver Disease.

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Article. 10.3390/biom11121808. 2021


Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Article. 10.1111/apt.16100. 2021


Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

Manzardo, C; (...); FIPSE LT-HIV Investigators

Article. 10.1111/ajt.14996. 2018


Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study (vol 18, pg 2513, 2018)

Manzardo, C.; (...); Samuel, D.

Article. 2018


Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study (vol 18, pg 2513, 2018)

Manzardo, C.; (...); Samuel, D.

Correction. 10.1111/ajt.15244. 2019


Disease Reversibility in Patients With Post-Hepatitis C Cirrhosis: Is the Point of No Return the Same Before and After Liver Transplantation? A Review

Vinaixa, C, Strasser, SI, Berenguer, M

Review. 10.1097/TP.0000000000001633. 2017


Distinct features of hepatitis delta in a Mediterranean setting

Hernandez-Evole, H, Berenguer-Haym, M

Meeting Abstract. 10.1016/S0618-8278(19)30486-4. 2019


Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids

Robles-Diaz M; (...); SLatinDILI Network

Article. 10.1111/apt.13023. 2015


DISTINGUISHING DRUG INDUCED AUTOIMMUNE HEPATITIS FROM IDIOPATIC AUTOIMMUNE HEPATITIS

Ortega-Alonso, A.; (...); Lucena, M. I.

Article. 10.1016/S0168-8278(15)31294-0. 2015


Does colectomy improve survival in patients with ulcerative colitis undergoing liver transplant for autoimmune liver diseases?

Trapero-Marugan, M.; (...); Cuervas-Mons, V.

Meeting Abstract. 2023


Does Surgeon Fatigue Influence the Results of Liver Transplantation?

Bosca, A; (...); Lopez-Andujar, R

Article. 10.1016/j.transproceed.2018.03.139. 2019


DRESS cases included in the Spanish and Latin-American DILI registries: clinical phenotype and outcome

Medina-Caliz, I; (...); Andrade, RJ

Meeting Abstract. 10.1016/S0168-8278(18)31459-4. 2018


Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study

De Simone, P; (...); Samuel, D

Article. 10.1097/TP.0000000000001171. 2016


Early liver transplantation for acute alcoholic hepatitis In a spanish liver transplant center

Aguilera Sancho, Victoria; (...); Berenguer, Marina

Meeting Abstract. 2023


Early predictors of corticosteroid response in acute severe autoimmune hepatitis: A nationwide multicenter study

Tellez, Luis; (...); Albillos, Agustin

Article. 10.1111/apt.16926. 2022


Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation.

Cortesi, Paolo Angelo; (...); Belli, Luca Saverio

Article. 10.3389/ti.2023.10954. 2023


Effect of season and sunlight on viral kinetics during hepatitis C virus therapy.

Hernandez-Alvarez, N; (...); Hernandez-Guerra, M

Article. 10.1136/bmjgast-2016-000115. 2017


Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis

Salmerón J; (...); Quiles R

Article. 10.3748/wjg.v21.i30.9163. 2015


Effectiveness and safety of ombitasvir, paritaprevir, ritonavir +/- dasabuvir +/- ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

Perello, C; (...); Spanish Collaborative Group for the Study of the Use of Hepatitis C Direct-Actin

Article. 10.1111/jvh.12637. 2017


EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT

Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado

Meeting Abstract. 2023


Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

Alonso, S; (...); Fernandez-Rodriguez, CM

Article. 10.1111/jvh.12648. 2017


Effectiveness of 8 weeks of glecaprevir/pibrentasvir in treatment-naive hepatitis C patients with liver cirrhosis: results from the real-world Spanish Hepa-C registry

Turnes, Juan; (...); Perez Cachafeiro, Santiago

Meeting Abstract. 2020


Effectiveness of ribavirin use associated with direct-acting antivirals in the treatment of non-cirrhotic patients with genotype 1a or 4 HCV infection in real-world practice

Ruiz-Antoran, B; (...); Panero, JLC

Meeting Abstract. 10.1016/S0168-8278(17)31448-4. 2017


EFFECTIVENESS OF TRIPLE THERAPY WITH BOCEPREVIR OR TELAPREVIR IN A MULTICENTRE CLINICAL PRACTICE COHORT OF HCV TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED HEPATIC FIBROSIS. SVR-12W AFTER TREATMENT

FERNANDEZ, C.; (...); Salmeron, J.

Article. 10.1016/S0168-8278(14)61360-X. 2014


Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

Calleja, JL; (...); Spanish Group for the Study of the Use of Direct-acting Drugs Hepatitis C Collab

Article. 10.1016/j.jhep.2017.01.028. 2017


Effectiveness, safety/tolerability of OBV/PTV/r DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.

Londoño MC; (...); García-Buey L

Article. 10.1371/journal.pone.0221567. 2019


Effectiveness, safety/tolerability of OBV/PTV/r +/- DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb/V and dialysis in Spanish clinical practice - preliminary data Vie-KinD study

Londono, MC; (...); De Alvaro, C

Meeting Abstract. 10.1016/S0168-8278(17)31920-7. 2017


Effects of high-resolution esophageal manometry on oxygen saturation and hemodynamic function

Ortiz, V; (...); Garrigues, V

Article. 10.1111/dote.12523. 2017


Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study

Salcedo, M; (...); Bañares R

Article. 10.1111/tri.12999. 2017


Efficacy and safety of glecaprevir/pibrentasvir for the pangenotypic treatment of chronic hepatitis C in former intravenous drug users: Subanalysis from a Spanish real-world cohort (Hepa-C)

Puigvehi, M; (...); Carrion, JA

Meeting Abstract. 10.1016/S0618-8278(19)30399-8. 2019


Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort

Sanchez Antolin G; (...); Castells L

Article. 10.1016/j.transproceed.2016.08.034. 2016


Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C

Fernández I; (...); Londoño MC

Article. 10.1016/j.jhep.2016.12.020. 2017


EFFICACY OF OBETICHOLIC ACID (OCA) VS PLACEBO AND EXTERNAL CONTROL (EC) ON CLINICAL OUTCOMES IN PRIMARY BILIARY CHOLANGITIS (PBC)

Kowdley, Kris V.; (...); Villamil, Alejandra

Meeting Abstract. 2023


Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C

Forns X; (...); Van Solingen-Ristea R

Article. 2016


Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study

Forns, X; (...); Jessner, W

Article. 10.1111/tid.12696. 2017


Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study.

Forns, Xavier; (...); Jessner, Wolfgang

Article. 2017


Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)

Crespo, J; (...); Antolin, GS

Article. 10.17235/reed.2019.6700/2019. 2019


Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH).

Crespo J; (...); Sánchez Antolín G

Article. 10.1016/j.gastrohep.2019.09.002. 2019


ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients

Belli, LS; (...); Strazzabosco, M

Review. 10.1016/j.jhep.2017.03.006. 2017


ELITA consensus statements on use of DAAs in liver transplant candidates and recipients.

Belli, Luca S; (...); ELITA board members

Guideline. 2017


Enhanced recovery after surgery programs improve short-term outcomes after liver transplantation-A systematic review and meta-analysis

Tinguely, Pascale; (...); Spiro, Michael

Article. 10.1111/ctr.14453. 2021


Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference.

Pollok, Joerg M.; (...); Spiro, Michael

Article. 10.1016/S2468-1253(22)00268-0. 2023


Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities

Buti M; (...); Gila A

Article. 10.1097/MEG.0000000000000195. 2015


Epidemiological pattern, incidence and outcomes of COVID-19 in liver transplant patients.

Colmenero J; (...); Pons JA

Article. 10.1016/j.jhep.2020.07.040. 2021


Equally Interchangeable? How Sex and Gender Affect Transplantation

Melk, A; (...); Berenguer, M

Review. 10.1097/TP.0000000000002655. 2019


Erratum to: "Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17-25).

Ampuero J; (...); Romero-Gómez M

Correction. 10.1016/j.jhep.2020.06.018. 2020


Ertapenem neurotoxicity in liver transplantation.

Martinez Delgado, Sara; (...); Conde, Isabel

Article. 10.17235/reed.2021.8469/2021. 2022


ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process.

Cillo U; (...); Selzner N

Review. 10.3389/ti.2022.10915. 2022


Estrategias para evitar la recidiva viral B despues del trasplante hepatico.

Prieto M, García-Eliz M

Abstract of Published Item. 10.1016/S0210-5705(14)70067-6. 2014


European and American Temporal Trends and Outcomes in Liver Transplant (LT) Patients with Human Immunodeficiency Virus (HIV)

Campos-Varela, I; (...); Terrault, N

Meeting Abstract. 2017


European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation.

Berenguer M; (...); Zubair H

Article. 10.3389/ti.2023.11358. 2023


Evaluation and Management of Liver Transplant Candidates With Prior Nonhepatic Cancer: Guidelines From the ILTS/SETH Consensus Conference.

Salcedo, Magdalena; (...); Line, Pal-Dag

Article. 10.1097/TP.0000000000003997. 2022


Everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study.

Gómez-Bravo M; (...); Santoyo J

Article. 10.17235/reed.2022.8549/2021. 2022


Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study

Gustot, Thierry; (...); Jalan, Rajiv

Meeting Abstract. 2024


Exchangeable copper for patients with Wilson disease at follow-up: rethinking normal ranges or changing methodology.

Marino, Zoe; (...); Berenguer, Marina

Article. 10.1097/HEP.0000000000001105. 2024


EXCHANGEABLE COPPER QUANTIFICATION FELLS BELOW NORMAL RANGE IN A HIGH PROPORTION OF PATIENTS WITH WILSON DISEASE DURING FOLLOW-UP

Mendez, Zoe Marino; (...); Berenguer, Marina

Meeting Abstract. 2024


Exchangeable copper quantification fells belownormal range in a high proportion of patients withWilson disease during follow-up

Marino, Zoe; (...); Berenguer, Marina

Meeting Abstract. 2024


Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management

Jadoul, M; (...); Martin, P

Article. 10.1016/j.kint.2018.06.011. 2018


EXPERT CONSENSUS CRITERIA AND PRACTICAL RECOMMENDATIONS FOR PBC CARE IN THE COVID-19 ERA AND BEYOND

Berenguer, Marina; (...); Carbone, Marco

Meeting Abstract. 2021


Exploring pregnancy, breastfeeding and contraception among women with Wilson disease in Spain: results from the Spanish Wilson registry

Romero-Gutierrez, Marta; (...); Marino, Zoe

Meeting Abstract. 2023


External validation of models to predict hepatocellular carcinoma (HCC) in HCV SVR F3-F4 patients

Sahuco, Ivan; (...); Berenguer, Marina

Meeting Abstract. 2023


External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3-F4 patients.

Carvalho-Gomes Â; (...); Berenguer M

Article. 10.1002/ueg2.12571. 2024


Fat and liver transplantation: clinical implications

Vinaixa, C, Selzner, N, Berenguer, M

Review. 10.1111/tri.13288. 2018


Fat, cancer, the gut-liver axis and rare liver diseases

Berenguer, Marina

Editorial Material. 2020

  • Open Access.

Fat, cancer, the gut-liver axis and rare liver diseases.

Berenguer M

Editorial Material. 10.1016/j.jhepr.2020.100189. 2020


FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis

Martinez-Arenas, Laura; (...); Berenguer, Marina

Meeting Abstract. 2024


FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis

Martinez-Arenas, L.; (...); Berenguer, M.

Meeting Abstract. 2024


FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH.

Martinez-Arenas, Laura; (...); Berenguer, Marina

Article. 10.1111/liv.16085. 2024


First nationwide genetic study on Wilson disease (Spanish Wilson registry): high diversity in mutations and in use of genetic evaluation, association with clinical data and influence on diagnosis and health costs

Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis

Meeting Abstract. 2023


FIRST REAL CLINICAL PRACTICE DATA IN SPAIN ON SOFOSBUVIR, SIMEPREVIR AND DACLATASVIR IN POST-TRANSPLANT HCV RECURRENCE: THE HepatiC REGISTRY EXPERIENCE

Prieto, M.; (...); Forns, X.

Article. 10.1016/S0168-8278(15)30988-0. 2015


Frailty and Sarcopenia in Acute-on-Chronic Liver Failure

Renau, LP; (...); Berenguer M

Article. 10.1002/hep4.1722. 2021


Frailty changes after liver transplantation in the Spanish setting. Results from a Spanish multicentre prospective cohort study

Puchades, L.; (...); Berenguer, M.

Meeting Abstract. 2023


Frailty Changes After Liver Transplantation. Results From a Spanish Multicenter Prospective Cohort Study

Puchades, Lorena; (...); Berenguer, Marina

Article. 10.1097/TXD.0000000000001599. 2024


Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients

Di Maira, Tommaso; (...); Berenguer, Marina

Article. 10.1002/lt.24128. 2015


GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study.

Rodríguez-Perálvarez ML; (...); Gastaca M

Article. 10.1016/j.eclinm.2024.102737. 2024


GENDER AND RACIAL DISCRIMINATION AMONG LIVER TRANSPLANTATION PROFESSIONALS: A SURVEY FROM ILTS EDI COMMITTEE

Andacoglu, Oya; (...); Selzner, Nazia

Meeting Abstract. 2021


Gender and racial discrimination among liver transplantation professionals: report of a global survey

Aguilera, V.; (...); Selzner, N.

Article. 2022


Gender and Racial Disparity Among Liver Transplantation Professionals: Report of a Global Survey

Aguilera, Victoria; (...); Selzner, Nazia

Article. 10.3389/ti.2022.10506. 2022


Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort

Conde, Isabel; (...); Aguilera Sancho, Victoria

Meeting Abstract. 2023


Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort

Conde, I.; (...); Aguilera, V.

Meeting Abstract. 2023


Genetics of Wilson disease and Wilson-like phenotype in a clinical series from eastern Spain.

Sánchez-Monteagudo A; (...); Espinós C

Article. 10.1111/cge.13719. 2020


Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population

Bosó V; (...); Aliño SF

Article. 10.1097/FTD.0b013e3182a94e65. 2014


Good posttransplant outcome using donors after cardiac death (DCD) when applying strict selection criteria

de la Varga, MF; (...); Castillo, MP

Meeting Abstract. 2021


Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: A propensity-score matched-cohort study.

Fernandez-de la Varga, Margarita; (...); Aguilera, Victoria

Article. 10.1016/j.aohep.2022.100724. 2022


Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH)

Calleja, JL; (...); Pineda, JA

Article. 10.1016/j.gastrohep.2018.07.010. 2018


Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir.

Rodríguez-Medina B; (...); Berenguer M

Article. 10.1016/S1665-2681(19)31305-5. 2013


HCV cirrhosis: liver volume as a non-invasive predictor of liver recovery post DAA treatment

Di Maira, T; (...); Berenguer, M

Meeting Abstract. 10.1016/S0168-8278(17)31568-4. 2017


HCV-Induced Immune Responses Influence the Development of Operational Tolerance After Liver Transplantation in Humans

Bohne, Felix; (...); Sanchez-Fueyo, Alberto

Article. 10.1126/scitranslmed.3008793. 2014


Health-Related Quality of Life in Patients Living with Wilson Disease in Spain: A Cross-Sectional Observational Study.

Marino, Zoe; (...); Anguera, Anna

Article. 10.3390/jcm12144823. 2023


Heat stroke and fulminant hepatitis: Conservative management or liver transplant?

Ladrón Abia P; (...); Berenguer Haym MC

Letter. 10.1016/j.gastrohep.2020.11.004. 2021


Hepamet Score: a new non-invasive method for NAFLD-related fibrosis screening in clinical practice

Ampuero, J; (...); Gomez, MR

Meeting Abstract. 10.1016/S0168-8278(18)30415-X. 2018


Hepatic nerve endings are rewired by cholestatic injury to connect inflamed lymphatics to sites of ductular remodelling

Noon, Luke; (...); Lloyd, Alison

Meeting Abstract. 2023


Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies

Catala-Senent, Jose F.; (...); Garcia-Garcia, Francisco

Article. 10.1186/s13293-021-00368-1. 2021


Hepatitis B surface antigen loss after discontinuing nucleos(t)ide analogue for treatment of chronic hepatitis B patients is persistent in White patients

Suarez, E; (...); Simon, MA

Article. 10.1097/MEG.0000000000001289. 2019


Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin

Buti M; (...); Esteban R

Article. 10.1111/tid.12360. 2015


Hepatitis B virus recurrence after liver transplantation and evolution of viral quasispecies

Buti, Maria; (...); Rodriguez-Frias, Francisco

Article. 2014


Hepatitis C Virus Recurrence After Liver Transplantation: How to Treat and When

Aguilera V

Article. 10.1016/j.transproceed.2014.09.177. 2014


Hepatitis C Virus-Associated Cholestatic Hepatitis: We Cannot Seem to Agree on Diagnostic Criteria

Berenguer, Marina, McCaughan, Geoffrey

Discussion. 2013


Hepatitis C virus-associated cholestatic hepatitis: we cannot seem to agree on diagnostic criteria.

Berenguer M, McCaughan G

Editorial Material. 10.1002/lt.23580. 2013


Hepatitis C-related cirrhosis: Current status

Conde, I, Vinaixa, C, Berenguer, M

Review. 10.1016/j.medcli.2016.09.019. 2017


Hepatobiliary and Pancreatic: A fatal case of extensive splanchnic vein thrombosis in a patient with Covid-19

Del Hoyo, J.; (...); Aguilera, V

Editorial Material. 2020


Hepatobiliary and Pancreatic: A fatal case of extensive splanchnic vein thrombosis in a patient with Covid-19.

Del Hoyo J; (...); Aguilera V

Editorial Material. 10.1111/jgh.15174. 2020


HepatoPredict Accurately Selects Hepatocellular Carcinoma Patients for Liver Transplantation Regardless of Tumor Heterogeneity

Andrade, Rita; (...); Cardoso, Joana

Article. 10.3390/cancers17030500. 2025


Hepatorenal syndrome markedly impacts prognosis of patients with alcohol-associated hepatitis. Results from the spanish registry of alcohol-associated liver disease (REHALC)

Gratacos-Gines, Jordi; (...); Pose, Elisa

Meeting Abstract. 2024


High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain

Crespo J; (...); Hernández-Guerra M

Article. 10.1016/S1665-2681(19)31169-X. 2015


High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4

Mariño Z; (...); Forns, X

Article. 10.1111/liv.13470. 2017


HIV infection is not associated with increased cardiovascular (CV) risk in liver transplant (LT) recipients: a single centre comparative study

Vinaixa, C.; (...); Prieto, M.

Meeting Abstract. 2019


HIV Infection Is Not Associated with Increased Cardiovascular Risk in Liver Transplant Recipients: A Single Center Comparative Study

Herreras, J; (...); Berenguer, M

Meeting Abstract. 2018


Human immunodeficiency virus-infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study

Aguero, F; (...); FIPSE Investigators

Article. 10.1002/lt.24741. 2017


Iberogast-Induced Severe Hepatotoxicity Leading to Liver Transplantation

Sáez-González E; (...); Berenguer M

Letter. 10.1038/ajg.2016.260. 2016


IDENTIFICATION OF CANDIDATES FOR MASLD TREATMENT WITH INDETERMINATE VIBRATION- CONTROLLED TRANSIENT ELASTOGRAPHY

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Meeting Abstract. 2024


Identification of Candidates for MASLD Treatment With Indeterminate Vibration-Controlled Transient Elastography.

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Article. 10.1016/j.cgh.2024.10.014. 2024


Immunosuppression in liver transplant.

Di Maira T, Little EC, Berenguer M

Review. 10.1016/j.bpg.2020.101681. 2020


IMPACT OF ANTICOAGULANT THERAPY ON UPPER GASTROINTESTINAL BLEEDING (UGI) IN PATIENTS WITH LIVER CIRRHOSIS. RESULTS FROM A RETROSPECTIVE MULTICENTRIC CASE-CONTROL STUDY

Cerini, F.; (...); Garcia-Pagan, J. C.

Article. 10.1016/S0168-8278(14)60019-2. 2014


Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study

Cerini F; (...); Garcia-Pagán JC

Article. 10.1002/hep.27783. 2015


IMPACT OF COMORBIDITIES ON LIVER TRANSPLANTATION: A PROSPECTIVE AND MULTICENTRIC ANALYSIS

Serrano, Trinidad; (...); Salcedo, Magdalena

Meeting Abstract. 2023


Impact of comorbidities on liver transplantation: a prospective and multicentric study

Serrano, Trinidad; (...); Salcedo, Magdalena

Meeting Abstract. 2022


Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper.

Marjot, Thomas; (...); Cornberg, Markus

Article. 10.1016/j.jhep.2022.07.008. 2022


Impact of hepatitis C virus (HCV) antiviral treatment on the need for liver transplantation (LT)

Saez-Gonzalez, E; (...); Berenguer, M

Article. 10.1111/liv.13618. 2018


Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria

Beumer, Berend R.; (...); IJzermans, Jan N. M.

Article. 10.1002/jcsm.13053. 2022


Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria

Beumer, Berend; (...); Ijzermans, Jan

Meeting Abstract. 10.1002/jcsm.13053. 2022


Impact of obesity on transient elastography accuracy among patients with non-alcoholic fatty liver disease

Del Barrio Azaceta, Maria; (...); Crespo, Javier

Meeting Abstract. 2023


Impact of suffering Wilson disease in Spain: an observational cross-sectional multicenter study

Marino, Zoe; (...); Anguera, Anna

Meeting Abstract. 2023


Improved Renal Function in Liver Transplant Recipients Treated for Hepatitis C Virus With a Sustained Virological Response and Mild Chronic Kidney Disease

Blé M; (...); Berenguer M

Article. 10.1002/lt.23756. 2014


In vitro/in vivo screening of oxidative homeostasis and damage to DNA, protein, and lipids using UPLC/MS-MS

Carretero, A; (...); Lahoz, A

Article. 10.1007/s00216-014-7983-5. 2014


Inadequate social support decreases survival in decompensated liver cirrhosis patients.

García Morales N; (...); Cubiella, Joaquin

Article. 10.1016/j.gastrohep.2022.04.006. 2022


Incidence and prognostic impact of cancer after liver transplantation

Gastaca, M; (...); Rodriguez-Peralvarez, M

Meeting Abstract. 2021


Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study

Chafer, Isabel Terol; (...); Sancho, Victoria Aguilera

Meeting Abstract. 2023


Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study

Chafer, I. Terol; (...); Sancho-Tello, M. V. Aguilera

Meeting Abstract. 2023


Increased cardiovascular risk post-LT in HIV-infected patients? An ELTR based multicenter study

Vinaixa, C.; (...); Aguilera, M. V.

Meeting Abstract. 2024


Intensified blood glucose treatment in diabetic patients undergoing a liver transplant: impact on graft evolution at 3 months and at 5 years

Ramos-Prol, A.; (...); Merino-Torres, J. F.

Article. 10.1007/s40618-017-0810-z. 2018


Interferon-free therapy is effective and safe for hepatitis C recurrence in liver transplant hepatitis C virus/human immunodeficiency virus coinfected recipients: a case-control study

Londono, MC; (...); FIPSE Investigators

Meeting Abstract. 10.1016/S0168-8278(17)30669-4. 2017


International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation

Tsochatzis, E; (...); Berenguer, M

Review. 10.1097/TP.0000000000002433. 2019


International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates

Terrault, NA; (...); Berenguer, M

Review. 10.1097/TP.0000000000001708. 2017


International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients

Terrault, NA; (...); McCaughan, GW

Review. 10.1097/TP.0000000000001704. 2017


International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients

Charlton, M; (...); Saliba, F

Review. 10.1097/TP.0000000000002147. 2018


International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients (vol 102, pg 727, 2018)

Berenguer, M

Correction. 10.1097/TP.0000000000002535. 2019


International Liver Transplantation Society Global Census report: a first look at the pediatric liver transplantation activity around the world

Lopez-Verdugo, F; (...); Pediat Liver Transplantation

Meeting Abstract. 2021


International Living Donor Liver Transplant Registry - Initial progress towards transparent reporting of outcomes

Kantsedikas, I.; (...); Rela, M.

Meeting Abstract. 2024


Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies

Puchades Renau, L, Berenguer, M

Review. 10.1111/hdi.12647. 2018


Is hepatitis B immunoglobulin necessary for hepatitis D prophylaxis after liver transplantation? A retrospective multicenter study of a cohort of 174 patients

Rodriguez-Tajes, Sergio; (...); Forns, Xavier

Meeting Abstract. 2020


Kinetics of Cytomegalovirus Specific Polyfunctional T-Cell Responses Associated with Control of CMV Reactivation after Liver Transplantation.

Carvalho-Gomes, A; (...); Lopez-Labrador, FX

Meeting Abstract. 2018


Lack of effect of CMV reactivation in the outcome of HCV-infected liver transplant(LT)patients

Aguilera, Victoria; (...); Berenguer, Marina

Article. 2015


Last Gasps of the Hepatitis C Virus Dragon: Direct Acting Antiviral Failures and Hepatitis C Virus-Positive Donors

Berenguer M

Article. 10.1002/lt.24520. 2016


LATTICE radiotherapy: A one institution experience

Solero, I.; (...); Conde, A.

Meeting Abstract. 2023


Launch of the International Living Donor Liver Transplantation Outcomes Registry.

Staubli, Sebastian; (...); Rela, Mohamed

Letter. 10.1016/S2468-1253(23)00185-1. 2023


Lead-in period and week 8 as predictive tools for response to boceprevir therapy: a retrospective study of Spanish real clinical practice

Crespo J; (...); Calleja JL

Article. 10.1016/j.gastrohep.2015.04.002. 2015


Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

Manns, M; (...); SOLAR-2 Investigators

Article. 10.1016/S1473-3099(16)00052-9. 2016


Lessons from population genomics for Wilson disease: Prevalence, penetrance of mutations, clinical implications and design of regional screening programmes

Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis

Meeting Abstract. 2023


LIPID DROPLET MORPHOLOGY JUSTIFIES DISCORDANCES BETWEEN HEPATIC STEATOSIS GRADES AND MRI PROTON DENSITY FAT FRACTION

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Meeting Abstract. 2024


Liver transplant for porto-sinusoidal vascular disease (psvd): long-term outcome

Magaz, M; (...); Valdig

Meeting Abstract. 2021


Liver Transplantation 2023: Status Report, Current and Future Challenges.

Terrault, Norah A; (...); Heimbach, Julie

Article. 10.1016/j.cgh.2023.04.005. 2023


Liver Transplantation for Alcoholic Liver Disease

Addolorato G; (...); Berenguer M

Review. 10.1097/TP.0000000000001156. 2016


LIVER TRANSPLANTATION FOR NON-ALCOHOLIC STEATOHEPATITIS: LOW PREVALENCE REGIONS ARE CATCHING UP

Martinez Arenas, Laura; (...); Berenguer, Marina

Meeting Abstract. 2022


Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)

Belli, LS; (...); ELITA EF-CLIF Working Grp

Article. 10.1016/j.jhep.2021.03.030. 2021


Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome.

Magaz, Marta; (...); Garcia-Pagan, Juan Carlos

Article. 10.1097/TP.0000000000004444. 2022


Liver volume as a predictor of functional improvement post DAA treatment

Di Maira, T; (...); Berenguer, M

Meeting Abstract. 2017


Liver Volume as a Predictor of Functional Improvement Post-DAA Treatment

Di Maira, T; (...); Berenguer, M

Article. 10.1097/TP.0000000000001990. 2018


Liver Volume as a Predictor of Outcome after HCV Eradication in Cirrhotic Patients

Di Maira, T; (...); Berenguer, M

Meeting Abstract. 2017


Liver Websites

Levitsky J, Berenguer M

Editorial Material. 10.1097/TP.0000000000001359. 2016


LOCATION AND ALLOCATION: INEQUITY OF ACCESS TO LIVER TRANSPLANTATION FOR PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE GRADE 3 (ACLF-3) ACROSS EUROPE.

Artzner, Thierry; (...); Jalan, Rajiv

Meeting Abstract. 2021


Location and allocation: inequity of access to liver transplantation for patients with severe acute-on-chronic liver failure in Europe.

Artzner, Thierry; (...); Jalan, Rajiv

Article. 10.1002/lt.26499. 2022


Long term follow-up in HCV infected patients with end stage chronic kidney disease after DAA therapy

Martinez-Camprecios, J; (...); Buti, M

Meeting Abstract. 2021


Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice.

Gomez, E; (...); Fernandez-Rodriguez, C M

Article. 10.1111/apt.18004. 2024


Long-Term Complications After Liver Transplantation: Results at 15 Years After Transplantation

Berenguer, Marina; (...); Prieto, Martn

Article. 2015


Long-term Challenges After Solid Organ Transplantation: Summary of Expert Presentations From the Sandoz 5th Standalone Transplantation Meeting, 2017.

Legendre C; (...); Guthoff M

Article. 10.1097/TP.0000000000002316. 2018


Long-Term Effectiveness, Safety, and Patient- Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study

Roche B; (...); Samuel D

Article. 10.12659/AOT.936162. 2022


Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

Martinez-Camprecios, Joan; (...); Buti, Maria

Article. 10.1016/j.gastrohep.2022.12.004. 2023


Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry.

Heinemann M; (...); all the other contributing centers (www.eltr.org) and the European Liver and Int

Article. 10.1111/ajt.16864. 2022


Long-term outcome of 'long-term liver transplant survivors'.

Rubín A; (...); Berenguer M

Article. 10.1111/tri.12118. 2013


Long-term outcomes of the octogenarian donor liver recipient: The era of the new centurion.

Schneider S; (...); Berenguer M

Article. 10.1111/ctr.13629. 2019


Long-term patient and graft survival after liver transplantation for autoimmune hepatitis

Heinemann, Melina; (...); Schramm, Christoph

Meeting Abstract. 2020


Long-term prospective follow-up of a primary biliary cholangitis (PBC) multicenter cohort treated with Obeticholic Acid (OCA). Interaction effect of triple therapy with fibrates

Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado

Meeting Abstract. 2023


Long-term survival after liver transplantation for autoimmune hepatitis - results from the European Liver Transplant Registry.

Heinemann M; (...); Schramm C

Article. 10.1002/lt.25739. 2020


Long-term survival after living donor liver transplantation in primary sclerosing cholangitis

Liwinski, T; (...); Schramm, C

Meeting Abstract. 2021


Low penetrance of frequent ATP7B mutations explains the low prevalence of Wilson disease. Lessons from real-life registries.

Alonso-Castellano, Pablo; (...); Garcia-Villarreal, Luis

Article. 10.1016/j.dld.2024.09.002. 2024


MAGNETIC RESONANCE IMAGING-BASED BIOMARKER ACCURATELY IDENTIFIES PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND CLINICALLY SIGNIFICANT LIVER FIBROSIS: A MULTICENTER, INTERNATIONAL, VALIDATION STUDY

Arnouk, Joud; (...); Marti-Bonmati, Luis

Meeting Abstract. 2021


Magnetic resonance imaging-based biomarker accurately identifies patients with nonalcoholic steatohepatitis and significant liver fibrosis: a multicentre, international, validation study

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Meeting Abstract. 2022


Main clinical characteristics and evolutionary events among patients suffering Wilson disease in Spain: first results from the Spanish Wilson registry

Marino, Zoe; (...); Castillo, Pilar

Meeting Abstract. 2023


Management of anemia induced by triple therapy in patients with chronic hepatitis C: challenges, opportunities and recommendations.

Romero-Gómez M; (...); Calleja JL

Article. 10.1016/j.jhep.2013.07.014. 2013


Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update.

Ruiz-Arabi, Elisa; (...); Aguado, Jose Maria

Article. 10.1016/j.trre.2024.100875. 2024


Management of Established Small-for-size Syndrome in Post Living Donor Liver Transplantation: Medical, Radiological, and Surgical Interventions: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.

Kirchner, Varvara A.; (...); Rela, Mohamed

Article. 10.1097/TP.0000000000004771. 2023


Management of HCV in the liver transplant setting

Berenguer M

Review. 10.1016/j.clinre.2015.05.004. 2015


Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.

Rojas LE; (...); Aliño SF

Article. 10.1097/FPC.0b013e3283642fb3. 2013


Metabolic and biochemical phenotypes can distinguish different patterns of histological severity in biopsy-proven NAFLD

Gomez, EV; (...); Romero-Gomez, M

Meeting Abstract. 10.1016/S0168-8278(17)30584-6. 2017


Metabolic dysfunction-associated fatty liver disease increases cardiovascular risk regardless of classical risk factors

Del Barrio Azaceta, Maria; (...); Crespo, Javier

Meeting Abstract. 2022


Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcomes?

Herreras Lopez, Julia; (...); Aguilera, Victoria

Article. 10.17235/reed.2022.8384/2021. 2022


Metabolically unhealthy status impacts on the risk of significant liver injury in biopsy-proven NAFLD patients beyond obesity

Ampuero, J; (...); Gomez, MR

Meeting Abstract. 10.1016/S0168-8278(18)31941-X. 2018


Milan-out Criteria and Worse Intention-to-Treat Outcome Postliver Transplantation.

Herreras J; (...); Berenguer M

Article. 10.1097/TXD.0000000000000934. 2019


Mitochondrial bioenergetics boost macrophages activation promoting liver regeneration in metabolically compromised animals.

Goikoetxea-Usandizaga, Naroa; (...); Martínez-Chantar ML

Article. 10.1002/hep.32149. 2021


MORE THAN A THIRD OF UNTREATED PATIENTS WITH CHRONIC HEPATITIS DELTA HAVE A DECREASE OR REACH UNDETECTABLE LEVELS OF HDV-RNA DURING NATURAL HISTORY

Palom, A; (...); Ferret, MAB

Meeting Abstract. 2020


Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort.

Serrano MT; (...); Salcedo M

Article. 10.3389/ti.2022.10263. 2022


MRI-PDFF captures the whole spectrum of lipid composition beyond traditional histological evaluation of macrosteatosis

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Meeting Abstract. 2023


mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).

Riveiro-Barciela, Mar; (...); Esteban, Rafael

Article. 10.1016/j.gastrohep.2023.01.010. 2023


Multidisciplinary units in tertiary referral hospitals to improve management of Wilson disease

Bruguera M; (...); Mariño Z

Editorial Material. 10.1016/j.gastrohep.2016.06.003. 2016


Multidisciplinary units in tertiary referral hospitals to improve management of Wilson disease (vol 39, pg 571, 2016)

Bruguera, M; (...); Mariño Z

Correction. 10.1016/j.gastrohep.2017.02.005. 2017


Multidrug resistant bacterial infections after liver transplantation: prevalence, impact and associated risk factors

Martin-Mateos, Rosa; (...); Albillos, Agustin

Meeting Abstract. 2022


Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors

Martin-Mateos, R.; (...); Albillos, A.

Meeting Abstract. 2024


Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.

Martin-Mateos R; (...); Albillos A

Article. 10.1016/j.jhep.2024.02.023. 2024


Multidrug-resistant bacterial infections in patients with liver cirrhosis in a tertiary referral hospital

Bejar-Serrano, S; (...); Benlloch, S

Article. 10.1016/j.gastrohep.2018.07.017. 2019


Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.

Deek MP; (...); Sweeney C

Article. 10.1016/j.euo.2024.03.010. 2024


New ERAS in liver transplantation - Past, present, and next steps

Hannon, Vivienne N.; (...); ERAS4OLT Org Working Grp

Article. 10.1111/ctr.14625. 2022


New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease

Lopez-Riera, M; (...); Jover, R

Article. 10.3389/fpahr.2017.00003. 2017

  • Open Access.

Non-alcoholic steatohepatitis as liver transplant indication: similarities and differences between a high and a low prevalence countries

Martinez-Arenas, L.; (...); Berenguer, M.

Meeting Abstract. 2022


Non-alcoholic steatohepatitis is also becoming a major liver transplant indication in Spain, a historically low risk area

Martinez-Arenas, Laura; (...); Berenguer, Marina

Meeting Abstract. 2022


Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers

Lopez-Riera, M; (...); Jover, R

Article. 10.1038/s41598-018-28854-4. 2018


Noninvasive Prediction of Outcomes in Autoimmune Hepatitis-Related Cirrhosis.

Llovet, Laura-Patricia; (...); Londoño MC

Article. 10.1002/hep4.1889. 2022


Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt-TIPS, and strategies to improve the outcomes

Berenguer, M.

Review. 10.51821/86.2.11430. 2023


Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.

Reig, A; (...); Pares, A

Article. 10.14309/ajg.0000000000001343. 2021


Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

Hézode C; (...); Pol S

Article. 10.1016/S0140-6736(15)60159-3. 2015


Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

Hezode, Christophe; (...); Pol, Stanislas

Article. 2015


Ombitasvir/Paritaprevir/r and Dasabuvir with or without Ribavirin for HCV Patients with Post-Transplant Recurrence

Mantry, Parvez S.; (...); Forns, Xavier

Article. 2015


Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia

Forns X; (...); Everson G

Article. 10.1111/liv.12931. 2015


One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease

Palom, A; (...); Buti, M

Article. 10.1111/apt.16485. 2021


ON-TREATMENT VIROLOGIC RESPONSE AND TOLERABILITY OF SIMEPREVIR, DACLATASVIR AND RIBAVIRIN IN PATIENTS WITH RECURRENT HEPATITIS C VIRUS GENOTYPE 1b INFECTION AFTER ORTHOTOPIC LIVER TRANSPLANTATION (OLT): INTERIM DATA FROM THE PHASE II SATURN STUDY

Forns, X.; (...); Witek, J.

Article. 10.1016/S0168-8278(15)30011-8. 2015


Open wound and cutaneous fistulization after microwave ablation of hepatocarcinoma.

Ladron Abia, Pablo; (...); Aguilera, Victoria

Article. 10.17235/reed.2022.8663/2022. 2022


Optimal management of perioperative analgesia regarding immediate and short-term outcomes after liver transplantation - A systematic review, meta-analysis and expert panel recommendations

Sun, Li-Ying; (...); ERAS4OLT Org Working Grp

Review. 10.1111/ctr.14640. 2022


Optimization of treatment in patients with primary biliary cholangitis: Gamma-glutamyl transferase levels as an early prognostic marker for ursodeoxycholic acid response. Results from the ColHai registry

Fernandez-Gordon Sanchez, Flor M.; (...); Gomez-Dominguez, Elena

Meeting Abstract. 2024


Out of Milan criteria and worse intetion to treat results at large liver transplant center

Lopez, JH; (...); Haym, MB

Meeting Abstract. 10.1016/S0168-8278(18)30613-5. 2018


Outcome of liver transplant candidates "delisted" after successful treatment of HCV infection

Perricone, G; (...); ELITA

Meeting Abstract. 2018


Outcomes in liver transplantation: Does sex matter?

Sarkar M; (...); Berenguer M

Review. 10.1016/j.jhep.2014.11.023. 2015


Out-of-Milan criteria and worse intention-to-treat results at a large liver transplant (LT) centre

Herreras, J; (...); Berenguer, M

Meeting Abstract. 2018


Out-of-Milan HCC criteria and worse intention-to-treat results following liver transplantation

Herreras, J.; (...); Berenguer, M.

Meeting Abstract. 2019


OVERCOMING BARRIERS TO CARE FOR DELTA INFECTED PATIENTS

Carvalho-Gomes, Angela; (...); Berenguer, Marina

Meeting Abstract. 2022


Overcoming barriers to care for Delta infected patients

Bono, Ariadna; (...); Berenguer, Marina

Meeting Abstract. 2023


Overcoming drug resistance in HSV, CMV, HBV and HCV infection

López-Labrador FX, Berenguer M, Navarro D

Review. 10.2217/fmb.15.74. 2015


Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease.

Marques, Patrice; (...); Sanz, Maria-Jesus

Article. 10.3390/ijms24032313. 2023


Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation

Pilar Ballester, Maria; (...); Nicastro, Emanuele

Meeting Abstract. 2024


Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease.

Marti-Aguado D; (...); Marti-Bonmati L

Article. 10.3389/fendo.2023.1213441. 2023


Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study

Castells L; (...); FIPSE LT-HIV Investigators

Article. 10.1016/j.jhep.2014.07.034. 2015


Performance of the fibroscan and other noninvasive scales for detecting hepatic fibrosis in patients with nonalcoholic fatty liver disease

Saez, E; (...); Zaragoza, A

Meeting Abstract. 10.1016/S0168-8278(17)30585-8. 2017


Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance

Pallares, C; (...); Lopez-Labrador, FX

Article. 10.1016/j.jcv.2018.02.016. 2018


Periesophageal Lymph Node Metastasis of Prostate Adenocarcinoma From Liver Transplant Donor

Sanchez-Montes, C; (...); Arguello, L

Editorial Material. 10.14309/ajg.0000000000000135. 2019


Peritransplant Antiviral Treatment of Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients

Vinaixa, C; (...); Prieto, M

Letter. 10.1002/lt.25297. 2018


Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir/Sofosbuvir Plus Ribavirin Pretransplant

Vinaixa, C, Berenguer, M

Editorial Material. 10.5604/16652681.1235470. 2017


Phenotypic and genotypic characterization of drug-induced liver injury (DILI) with autoimmune features

Stephens, C.; (...); Andrade, Raul J.

Article. 2015


PHYSICAL FRAILTY IN LIVER TRANSPLANTATION.

Puchades Renau L; (...); Berenguer Haym M

Review. 10.17235/reed.2020.7448/2020. 2021


Pilot validation study of a rapid test in oral fluid for population screening of hepatitis C virus infection

Pallares, C; (...); Berenguer, M

Meeting Abstract. 10.1016/S0168-8278(17)31165-0. 2017


Population screening using a point-of-care test reveals unexpectedly low prevalence of active HCV infection in Spain

Carvalho-Gomes, A; (...); Berenguer, M

Meeting Abstract. 2017


Porto sinusoidal vascular liver disorder: natural history and long-term outcome

Magaz, Marta; (...); Garcia Pagan, Juan Carlos

Meeting Abstract. 2023


Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome.

Magaz, Marta; (...); Garcia-Pagan, Juan Carlos

Article. 10.1016/j.jhep.2024.07.035. 2024


Post Living Donor Liver Transplantation Small-for-size Syndrome: Definitions, Timelines, Biochemical, and Clinical Factors for Diagnosis: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.

Kow, Alfred Wei Chieh; (...); Ikegami, Toru

Article. 10.1097/TP.0000000000004770. 2023


Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference

Berenguer, M; (...); van der Laan, LJW

Review. 10.1097/TP.0000000000003196. 2020


Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.

Castelló B; (...); Berenguer M

Article. 10.1016/j.aohep.2019.06.014. 2019


PREDICTION OF BIOCHEMICAL RESPONSE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID: DERIVATION AND EXTERNAL VALIDATION OF THE OCA RESPONSE SCORE (ORS)

De Vincentis, Antonio; (...); Carbone, Marco

Meeting Abstract. 2023


Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.

Ampuero J; (...); Fernández-Rodríguez C

Article. 10.1097/HEP.0000000000000826. 2024


Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence

Song AT; (...); Samuel D

Article. 10.3748/wjg.v22.i18.4547. 2016


Predictive factors of response to corticosteroid therapy in acute severe autoinmune hepatitis: a national multicentric study

Sanchez Rodriguez, Eugenia; (...); Albillos, Agustin

Meeting Abstract. 2020


PREDICTIVE FACTORS OF SURVIVAL AND PROGNOSTIC SCORE VALIDATION IN LIVER RETRANSPLANTATION FOR SEVERE HEPATITIS C RECURRENCE: THE IMPORTANCE OF HCV THERAPY BEFORE AND AFTER RETRANSPLANTATION

Song, A. T. W.; (...); Samuel, D.

Article. 10.1016/S0168-8278(13)60186-5. 2013


Pregnancy and autoimmune hepatitis: presentation and outcomes

Llovet, LP; (...); Londono, MC

Meeting Abstract. 10.1016/S0168-8278(18)30683-4. 2018


Presentation and Outcomes of Pregnancy in Patients With Autoimmune Hepatitis.

Llovet LP; (...); Londoño MC

Letter. 10.1016/j.cgh.2018.12.030. 2019


Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.

Hakeem AR; (...); Rela M

Article. 10.1097/TP.0000000000004769. 2023


Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.

Awan, Ahmed Arslan Yousuf; (...); Jadoul, Michel

Article. 10.7326/M23-2391. 2023


Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline

Gordon, CE; (...); Martin, P

Article. 10.7326/M19-1539. 2019


Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes.

Ampuero J; (...); Molina E

Letter. 10.1136/gutjnl-2021-325700. 2021


Primary biliary cholangitis in Spain. Results of a Delphi study of epidemiology, diagnosis, follow-up and treatment

Pares, A; (...); Gil, A

Article. 10.17235/reed.2018.5665/2018. 2018


Primary sclerosing cholangitis as an indication for liver transplantation. Results and conditioning factors: relationship with associated intestinal pathology

Fernandez, Ainhoa; (...); Salcedo, Magdalena

Meeting Abstract. 2023


Primary Sclerosing Cholangitis: Gender Effects in Valencia's Low-Prevalence Region.

Minguez, Alejandro; (...); Berenguer, Marina

Article. 10.1007/s10620-024-08368-y. 2024


Proceedings of the 25th Annual Congress of the International Liver Transplantation Society.

Chadha R; (...); Bhangui P

Review. 10.1097/TP.0000000000003160. 2020


Proceedings of the 26th Annual Virtual Congress of the International Liver Transplantation Society.

Kalisvaart, Marit; (...); Kirchner, Varvara

Article. 10.1097/TP.0000000000004183. 2022


Proceedings of the 27th Annual Congress of the International Liver Transplantation Society.

Campos-Varela, Isabel; (...); De Martin, Eleonora

Article. 10.1097/TP.0000000000004637. 2023


Proceedings of the 28th annual congress of the international liver transplantation society.

Shaji Mathew, Johns; (...); Chadha, Ryan

Article. 10.1097/LVT.0000000000000330. 2024


Proceedings of the 29th Annual Congress of the International Liver Transplantation Society.

Patel, Madhukar S; (...); Rammohan, Ashwin

Article. 10.1097/LVT.0000000000000593. 2025


Profile of plasma microRNAs as a potential biomarker of Wilson's disease.

Sanchez-Monteagudo, Ana; (...); Espinos, Carmen

Article. 10.1007/s00535-024-02135-6. 2024


Profiles and clinical management of hepatitis C patients in Spain: disHCovery study

Buti M; (...); Esteban R

Article. 2015


Profiles and clinical management of hepatitis C patients in Spain: disHCovery study (vol 28, pg 145, 2015)

Buti, Maria; (...); Esteban, Rafael

Article. 2015


Prognosis of severe HBV reactivation in Western countries: role of the MELD score

Poli, E; (...); Coilly, A

Meeting Abstract. 2021


Prognostic Value of Pre-transplantation Serum Alpha-Fetoprotein Levels in Hepatocellular Carcinoma Recurrence

Montalva EM; (...); Lopez-Andujar R

Article. 10.1016/j.transproceed.2016.07.033. 2016


Prognosticating hepatocellular carcinoma before and after liver transplantation with HepatoPredict

Silva, Silvia Gomes; (...); Cardoso, Joana

Meeting Abstract. 2024


Progress in hepatitis C treatment

Vinaixa, Carmen, Aguilera, Victoria, Berenguer, Marina

Review. 2013


Progression of liver fibrosis in post-transplant hepatitis C: mechanisms, assessment and treatment.

Berenguer M, Schuppan D

Article. 10.1016/j.jhep.2012.12.014. 2013


Protease inhibitors impair renal function in HCV-infected immunocompetent patients

Fernandez-Carrillo, Carlos; (...); Luis Calleja, Jose

Meeting Abstract. 2014


Protocol for an International Living Donor Liver Transplant Registry ! LDLTregistry.org

Turner, B.; (...); Salinas, C. Hidalgo

Meeting Abstract. 2023


Pushing the donor limits: Deceased donor liver transplantation using organs from octogenarian donors

Díaz Jaime F, Berenguer, M

Article. 10.1002/lt.24841. 2017


Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study

Buti, M; (...); Esteban, R

Article. 10.1371/journal.pone.0184550. 2017


Re: Tacrolimus Trough Concentrations after Liver Transplantation: .

Di Maira T; (...); Berenguer M

Letter. 10.1097/TP.0000000000003087. 2020


Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection

Crespo, J; (...); Spanish Group for the Study of the Use of Direct-acting Drugs Hepatitis C Collab

Article. 10.1016/j.cgh.2017.02.020. 2017


Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain.

Manuel Sousa J; (...); Manzanares A

Article. 10.1371/journal.pone.0225061. 2019


Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients

Aguiar, D; (...); Herrero, JI

Article. 10.12659/AOT.902523. 2017


Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction.

Crespo, Javier; (...); Calleja, Jose Luis

Practice Guideline. 10.1016/j.gastrohep.2022.09.009. 2023


Recommendations of everolimus use in liver transplant

Rubin Suarez, Angel; (...); Prieto Castillo, Martin

Review. 10.1016/j.gastrohep.2017.05.008. 2017


Recompensation following an episode of alcohol-associated hepatitis mostly occurs in the first year of follow-up and is related to Child-Pugh score, levels of GGT and platelets, and alcohol abstinence

Gratacos, Jordi; (...); Pose, Elisa

Meeting Abstract. 2023


Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Clinical Patterns and Hierarchy of Salvage Treatments

Giuliani, Tommaso; (...); Lopez-Andujar, Rafael

Article. 10.1159/000539460. 2024


Recurrent alcohol-associated hepatitis is common and is associated with increased mortality.

Gratacos-Gines, Jordi; (...); Pose, Elisa

Article. 10.1097/HEP.0000000000000825. 2024


Re-irradiation in NSCLC High-dose RT: Control, Survival and Toxicity

Germain, J.; (...); Conde, A.

Meeting Abstract. 2023


Remnant vital tissue following locoregional therapy for hepatocellular carcinoma: another player in the game

Rubin, A, Berenguer, M

Editorial Material. 10.1111/tri.13274. 2018


Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain

Bilbao I; (...); Guilera M

Article. 10.1002/lt.24172. 2015


Reply to: "Renal impairment and anemia during triple therapy"

Romero-Gómez M; (...); Calleja JL

Letter. 10.1016/j.jhep.2014.01.007. 2014


Reproductive and pregnancy control in Wilson disease patients in Spain.

Romero-Gutiérrez M; (...); Mariño Z

Article. 10.1097/MEG.0000000000002831. 2024


Reversion of disease manifestations after HCV eradication

van der Meer AJ, Berenguer M

Review. 10.1016/j.jhep.2016.07.039. 2016


Rising indication of non-alcoholic steatohepatitis as transplant indication in historically low risk areas

Martinez-Arenas, L.; (...); Berenguer, M.

Meeting Abstract. 2022


Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies

Lucena, Ana; (...); Ampuero, Javier

Meeting Abstract. 2023


Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial

Puente Sanchez, Angela; (...); Garcia Pagan, Juan Carlos

Meeting Abstract. 2023


Safety and Efficacy of Interferon-free Antiviral Treatment in Patients with MELD over 20

Vinaixa, C; (...); Berenguer, M

Meeting Abstract. 2017


Safety and efficacy of ombitasvir/paritaprevir/ritonavir +/- dasabuvir and +/- ribavirin in adult renal or liver transplant recipients with HCV infection (CORAL-I: cohorts 3-6)

Agarwal, K; (...); Forns, X

Meeting Abstract. 10.1016/S0168-8278(17)31461-7. 2017


Selective Indication of T-Tube in Liver Transplantation: Prospective Validation of the Results of a Randomized Controlled Trial

Lopez-Andujar, R; (...); Montalva, EM

Article. 10.1016/j.transproceed.2018.03.133. 2019


Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant.

Mehta, Gautam; (...); Jalan, Rajiv

Article. 10.1097/HC9.0000000000000273. 2023


Sexual Dysfunction in Cirrhotic Patients Awaiting Liver Transplantation.

Rodriguez-Medina, Beatriz; (...); Berenguer, Marina

Article. 2013


Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation

Lens, S; (...); Forns, X

Article. 10.1111/liv.13858. 2018


Should organs from hepatitis C-positive donors be used in hepatitis C-negative recipients for liver transplantation?

Selzner, N, Berenguer, M

Article. 10.1002/lt.25072. 2018


Should we seek complete liver tests normalization in primary biliary cholangitis? Data from ColHai registry

Diaz-Gonzalez, Alvaro; (...); del Registro, Grupo

Meeting Abstract. 2022


Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH

Ampuero, J; (...); Gomez, MR

Article. 10.1016/j.jhep.2020.02.028. 2020


Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study

Berenguer, Marina; (...); GEMHEP

Article. 10.1016/j.gastrohep.2022.10.018. 2023


Significant heterogeneity in the diagnosis and management of Wilson Disease (WD): results from a large Spanish Registry.

Berenguer, M

Meeting Abstract. 2017


Significant impact of new oral therapies against HCV on the waiting list for liver transplantation in Spain.

Berenguer, M, de la Rosa Rodríguez G, Dominguez-Gil, B

Letter. 10.1016/j.jhep.2018.06.011. 2018


SIMILAR POST-TRANSPLANT OUTCOMES USING DONORS AFTER CARDIAC DEATH WHEN APPLYING STRICT SELECTION CRITERIA

de la Varga, MF; (...); Aguilera, V

Meeting Abstract. 2021


Similar rates of liver transplantation (LT) for acute liver failure (ALF) but changes in patient profiles in a Spanish multicentre cohort

Conde, I.; (...); Aguilera, V.

Meeting Abstract. 2023


Simple score to assess cardiovascular risk post-liver transplantation

Di Maira, T; (...); Berenguer, M

Meeting Abstract. 2021


SIMPLE SCORE TO ASSESS CARDIOVASCULAR RISK POST-LIVER TRANSPLANTATION

Di Maira, Tommaso; (...); Berenguer, Marina

Meeting Abstract. 2022


Sinusoidal Obstruction Syndrome after Liver Transplantation: A Multicenter Observational Study.

Caballero-Marcos A; (...); Salcedo M

Article. 10.1002/lt.26452. 2022


Sofosbuvir Compassionate Use Program for Patients With Severe Recurrent Hepatitis C After Liver Transplantation

Forns X; (...); Habersetzer F

Article. 10.1002/hep.27681. 2015


Stretching the boundaries for liver transplant in the 21st century

Trapero-Marugan, M, Little, EC, Berenguer, M

Review. 10.1016/S2468-1253(18)30213-9. 2018


Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we?

Cabezas, Joaquin; (...); Crespo, Javier

Meeting Abstract. 2023


SURVEY TO EVALUATE THE IMPLEMENTATION OF THE RECOMMENDATIONS ON THE COMPREHENSIVE DIAGNOSIS OF VIRAL HEPATITIS IN A SINGLE EXTRACTION: WHERE ARE WE?

Cabezas, Joaquin; (...); Crespo Garcia, Javier

Meeting Abstract. 2023


Temporal Trends and Outcomes in Liver Transplantation for Recipients with Human Immunodeficiency Virus Infection in Europe and United States.

Campos-Varela I; (...); Terrault NA

Article. 10.1097/TP.0000000000003107. 2019


TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)

Buti, M.; (...); Esteban, R.

Article. 10.1016/S0168-8278(14)61200-9. 2014


TENOFOVIR MONOTHERAPY VERSUS LAMIVUDINE PLUS ADEFOVIR IN LAMIVUDINE-FAILURE PATIENTS RESCUED WITH LAMIVUDINE PLUS ADEFOVIR COMBINATION: INTERIM ANALYSIS OF THE TENOSIMP-B CLINICAL TRIAL

Jorquera, F.; (...); Rodriguez, M.

Article. 10.1016/S0168-8278(14)61201-0. 2014


Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study

Rodriguez, M; (...); TENOSIMP-B Res Grp

Article. 10.3748/wjg.v23.i41.7459. 2017


The 2024 ILTS-ILCA consensus recommendations for liver transplantation for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Kodali, Sudha; (...); Sapisochin, Gonzalo

Article. 10.1097/LVT.0000000000000589. 2025


The combination of HEPAmet fibrosis score and transient elastography shows a high diagnostic accuracy in predicting advanced fibrosis in NAFLD

Ampuero, J; (...); Gomez, MR

Meeting Abstract. 10.1016/S0618-8278(19)30234-8. 2019


The concentration of HDV-RNA correlates with the probability of developing clinical events in patients with chronic hepatitis D

Palom, Adriana; (...); Buti, Maria

Meeting Abstract. 2024


The changing face of hepatology.

Berenguer M

Editorial Material. 10.1016/j.jhepr.2019.11.003. 2019


The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease

Young, J; (...); Calleja, JL

Article. 10.1186/s12879-016-2106-x. 2017


The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity

Ampuero, J; (...); HEPAmet Registry

Article. 10.1111/apt.15015. 2018


The Era of the New Centurion: Long Term Outcomes of the Octogenarian Liver

Diaz, FC; (...); Berenguer, M

Meeting Abstract. 2017


The first fifteen days of calcineurin inhibitors exposure do not predict post-transplant malignant outcomes

Di Maira, T; (...); Berenguer, M

Meeting Abstract. 2018


The global prospective observational study to evaluate the role of 'liver transplantation in patients with cirrhosis and severe acute-on-chronic liver failure (CHANCE)': study design, demographics and overall outcome

Gustot, Thierry; (...); Jalan, Rajiv

Meeting Abstract. 2024


The ILTS Consensus Conference on NAFLD/NASH and Liver Transplantation: Setting the Stage

Burra, P, Berenguer, M, Pomfret, E

Article. 10.1097/TP.0000000000002507. 2019


The ILTS-SETH Consensus Conference on Extrahepatic Cancer and Liver Transplantation: Paving the Way.

Colmenero J, Berenguer M, Watt KD

Article. 10.1097/TP.0000000000003994. 2022


The impact of COVID-19 on liver transplant (LT) centers across the world during the first wave: a Multisociety Survey (EASL-ESOT/ELITA-ILTS)

Russo, FP; (...); Polak, W

Meeting Abstract. 2021


THE IMPACT OF DIRECT ACTING ANTIVIRALS ON HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION: A MULTICENTRIC RETROSPECTIVE STUDY

Gorgen, A; (...); Sapisochin, G

Meeting Abstract. 2019


The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study

Gorgen, A; (...); Sapisochin, G

Article. 10.1097/TP.0000000000003115. 2020


The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients

Roman A; (...); Ussetti P

Article. 10.1016/j.trre.2014.01.001. 2014


The interaction between metabolic syndrome and alcohol consumption after an episode of alcohol-associated hepatitis is associated with increased mortality: results from de spanish registry of alcohol-associated liver disease (REHALC)

Gratacos-Gines, Jordi; (...); Pose, Elisa

Meeting Abstract. 2024


The metabolic dysfunction-associated fatty liver disease definition, regardless of its clinical subclassification, identifies patients at high risk for liver disease progression

Del Barrio Azaceta, Maria; (...); Crespo, Javier

Meeting Abstract. 2022


The New Era of Hepatitis C Therapy in Liver Transplant Recipients

Little, EC, Berenguer, M

Article. 10.1016/j.cld.2016.12.012. 2017


THE PRESENCE OF METABOLIC SYNDROME BEFORE TRANSPLANTATION INCREASE THE RISK OF CARDIOVASCULAR EVENTS FOLLOWING LIVER TRANSPLANTATION

Herreras, J; (...); Aguilera, V

Meeting Abstract. 2021


The Reality of Inadequate Patient Care and the Need for a Global Action Framework in Organ Donation and Transplantation.

Domínguez-Gil B; (...); Delmonico FL

Article. 10.1097/TP.0000000000004186. 2022


The road map toward an hepatitis C virus-free transplant population.

Berenguer, M; (...); Samuel, D

Article. 10.1111/ajt.14976. 2018


The role of early extubation on short-term outcomes after liver transplantation - A systematic review, meta-analysis and expert recommendations

Tinguely, Pascale; (...); ERAS4OLT Org Working Grp

Review. 10.1111/ctr.14642. 2022


The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis

Rodriguez-Tajes, Sergio; (...); Forns, Xavier

Article. 10.1111/liv.15777. 2024


The role of prehabilitation on short-term outcomes after liver transplantation - A review of the literature and expert panel recommendations.

Vinaixa C; (...); Samuel D

Article. 10.1111/ctr.14686. 2022


The role of preoperative optimization of the nutritional status on the improvement of short-term outcomes after liver transplantation? A review of the literature and expert panel recommendations

Victor, David W.; (...); ERAS4OLT Org Working Grp

Article. 10.1111/ctr.14647. 2022


The use of prophylactic strategies using hepatitis B immunoglobulin for hepatitis B recurrence after liver transplantation in routine clinical practice in Spain. Preliminary results of the 1st round of a delphi panel

Prieto, M; (...); Casado, MA

Meeting Abstract. 10.1016/S0168-8278(17)30671-2. 2017


Transaminase Pattern Over Time Is Not Associated with a More Aggressive Hepatic Evolution: Results from the AEEH Wilson Registry

Berenguer, Marina; (...); Marino, Zoe

Meeting Abstract. 2024


Transplant Oncology in Primary and Metastatic Liver Tumor: Principles, Evidence and Opportunities.

Sapisochin G; (...); Mazzaferro V

Article. 10.1097/SLA.0000000000004071. 2020


Transplantation: A Priority in the Healthcare Agenda.

Muller E; (...); Potena L

Article. 10.1097/TP.0000000000005182. 2025


Tratamiento de la hepatitis C en grupos de pacientes especiales.

Berenguer M; (...); Castellano G

Abstract of Published Item. 10.1016/S0210-5705(15)30004-2. 2014


Treating patients before and after transplant

Berenguer, M.

Article. 10.1111/jvh.12332_12. 2014


Treatment of Hepatitis C Virus Infection in Patients With Cirrhosis and Predictive Value of Model for End-Stage Liver Disease: Analysis of Data From the Hepa-C Registry

Fernández Carrillo C; (...); Calleja, JL

Article. 10.1002/hep.29097. 2017


TREATMENT-NAIVE STABLE LIVER TRANSPLANT PATIENTS WITH GENOTYPE-1 HCV INFECTION: PHARMACOKINETIC RESULTS OF ADJUSTED DOSING WITH TACROLIMUS OR CYCLOSPORINE IN THE TELAPREVIR REPLACE STUDY

Forns, X.; (...); Bertelsen, K.

Article. 2014


Trends in liver transplantation for acute liver failure. A Spanish multicenter study

Conde, Isabel; (...); Berenguer, Marina

Meeting Abstract. 2022


Trends in liver transplantation for acute liver failure: a Spanish multicenter study

Conde, I.; (...); Berenguer, M.

Meeting Abstract. 2022


Triple Therapy for HCV Cirrhosis in Liver Transplant Candidates. High Rate of Prevention of HCV Recurrence after Liver Transplantation (LT) in Well Selected Patients

Maria Braithwaite, Ana; (...); Berenguer, Marina

Article. 2014


T-tube or no T-tube in cadaveric orthotopic liver transplantation: the eternal dilemma: results of a prospective and randomized clinical trial.

López-Andújar R; (...); De Juan Burgueño M

Article. 10.1097/SLA.0b013e318286e0a0. 2013


Universal access to direct-acting antivirals treatment is not not enough to prevent late stage presentation of hepatitis C infection

Cabezas, J; (...); Crespo, J

Meeting Abstract. 10.1016/S0618-8278(19)30970-3. 2019


Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: Results from a multicenter Spanish study

Briceño J; (...); de la Mata M

Article. 10.1016/j.jhep.2014.05.039. 2014


Use of HBsAg-positive donors in liver transplantation: an ILTS-EASLAASLD multisociety survey

Vinaixa, C.; (...); Terrault, N.

Meeting Abstract. 2024


Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey.

Vinaixa, Carmen; (...); Berenguer, Marina

Article. 10.1097/LVT.0000000000000432. 2024


Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury

Robles-Diaz M; (...); Safer and Faster Evidence-based Translation Consortium

Article. 10.1053/j.gastro.2014.03.050. 2014


Validation of MELD3.0 in 2 centers from different continents.

Tejedor M; (...); Berenguer M

Article. 10.1097/HC9.0000000000000504. 2024


Validation of MELD3.0 in two centres from different continents

Tejedor Bravo, Marta; (...); Berenguer, Marina

Meeting Abstract. 2023


Validation of MELD3.0 in two centres from different continents

Tejedor, M.; (...); Berenguer, M.

Meeting Abstract. 2023


Validation of the gender-equity model for liver allocation (GEMA) in a nationwide cohort of liver transplant candidates in Spain

Rodriguez-Peralvarez, Manuel; (...); Gastaca, Mikel

Meeting Abstract. 2024


Validation of the liver frailty index as an adverse outcome predictor in the spanish liver transplant setting. Results from a spanish multicentre prospective cohort study.

Puchades, L.; (...); Berenguer, M.

Meeting Abstract. 2023


Variation in global living donor liver transplant surgical technique - early data from the International Living Donor Liver Transplant Registry (LDLTregistry.org)

Kantsedikas, I.; (...); Rela, M.

Meeting Abstract. 2024

  • Open Access.

Variation in global living donor liver transplant surgical technique: Early data from the International Living Donor Liver Transplant Registry

Kantsedikas, Ilya; (...); Rela, Mohamed

Meeting Abstract. 10.1097/01.tp.0001066152.18661.c6. 2024

  • Open Access.

Very early immunosuppression predicts the first-year renal function post liver transplantation

Di Maira, T.; (...); Berenguer, M.

Meeting Abstract. 2019


Very low access to early liver transplantation (LT) for acute alcoholic hepatitis (AAH) in a setting of social psychiatric contraindications

Garcia Garcia, S.; (...); Aguilera, V.

Meeting Abstract. 2023


VI consensus document by the Spanish Liver Transplantation Society

Pardo, F; (...); Briceno, J

Article. 10.1016/j.ciresp.2017.12.013. 2018


VI consensus document by the Spanish Liver Transplantation Society

Pardo, F; (...); Briceno, J

Article. 10.1016/j.gastrohep.2018.05.012. 2018


Waiting time dictates impact of frailty: A Spanish multicenter prospective study.

Puchades, Lorena; (...); Berenguer, Marina

Article. 10.1016/j.jhepr.2023.100840. 2023


What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery, or portal vein thrombosis? A systematic review of the literature and expert panel recommendations

Kirchner, Varvara A.; (...); ERAS4OLT Org Working Grp

Review. 2022

  • Open Access.

Wide variations in liver transplantation (LT) policies across Europe for patients with acute-on-chronic liver failure (ACLF) despite excellent post-LT survival: Results of a CLIF/ELITA collaborative study

Belli, Luca Saverio; (...); Arroyo, Vicente

Meeting Abstract. 2020


Wilson's Disease: Facing the Challenge of Diagnosing a Rare Disease

Sánchez-Monteagudo A; (...); Espinós C

Review. 10.3390/biomedicines9091100. 2021


Women are also disadvantaged in accessing transplant outside the United States: analysis of the spanish liver transplantation registry

Tejedor, Marta; (...); Berenguer, Marina

Meeting Abstract. 2024

  • Open Access.

Women Are Also Disadvantaged in Accessing Transplant Outside the United States: Analysis of the Spanish Liver Transplantation Registry.

Tejedor, Marta; (...); Berenguer, Marina

Article. 10.3389/ti.2024.12732. 2024


Worldwide variations in COVID-19 vaccination policies and practices in liver transplant settings: results of a multi-society global survey.

Di Maira, Tommaso; (...); Berenguer, Marina

Article. 10.3389/frtra.2023.1332616. 2023


Campos de estudio

Compartir